Article info
PDFCommentary
Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension
- Correspondence to Dr Krista Rombouts, Division of Medicine, Royal Free Hospital & University College London, Institute for Liver & Digestive Health, Rowland Hill Street, London NW3 2PF, UK; k.rombouts{at}ucl.ac.uk
Citation
Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension
Publication history
- Received June 3, 2014
- Revised June 7, 2014
- Accepted June 9, 2014
- First published June 25, 2014.
Online issue publication
October 26, 2017
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/